Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CVR6 | ISIN: FR00140048X2 | Ticker-Symbol: 9W8
Frankfurt
02.06.26 | 08:04
1,500 Euro
-0,66 % -0,010
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IKONISYS SA Chart 1 Jahr
5-Tage-Chart
IKONISYS SA 5-Tage-Chart
RealtimeGeldBriefZeit
1,5201,59002.06.

Aktuelle News zur IKONISYS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.05.Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden1
25.05.Aliko Scientific signs Brazil JV to manufacture FISH probes1
25.05.Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture421Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and...
► Artikel lesen
19.05.Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital302Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over...
► Artikel lesen
11.05.Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona406Regulatory News: Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics...
► Artikel lesen
IKONISYS Aktie jetzt für 0€ handeln
10.03.Aliko Scientific signs Italy distribution deal for bladder test1
10.03.Ikonisys: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market391Regulatory News: Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization in...
► Artikel lesen
24.02.Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform386Regulatory News: Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition...
► Artikel lesen
18.02.Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan431Regulatory News: Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution...
► Artikel lesen
23.12.25IKONISYS: Number of shares and voting rights of Ikonisys SA as of December 23, 20254
19.12.25Aliko Scientific raises €2.72 million through private placement and debt conversion3
19.12.25Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali480Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
04.12.25Ikonisys SA: Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born376Regulatory News: Hospitex international, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices...
► Artikel lesen
24.11.25Ikonisys SA: Ikonisys: Hospitex Initiates International Dialogues for Pilot Projects in Oncology Diagnostics Following ADB Delegation Visit490Regulatory News: Hospitex, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, announces...
► Artikel lesen
07.10.25Ikonisys SA: Hospitex Wins Public Tender at Policlinico di Bari for Cytofast Cytology Systems342Regulatory News: Hospitex,the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, has been...
► Artikel lesen
30.09.25XFRA 9W8: WIEDERAUFNAHME/RESUMPTION236FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
01.07.25Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report415Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...
► Artikel lesen
01.07.25XFRA 9W8: AUSSETZUNG/SUSPENSION439DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8...
► Artikel lesen
04.06.25ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics428Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) Euronext Growth: ALIKO, through its fully owned Italian subsidiary Hospitex International is pleased to announce the signing of an exclusive distribution...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1